Article Details

KYE Pharmaceuticals Files Accrufer® New Drug Submission in Canada for the Treatment of ...

Retrieved on: 2022-03-22 00:41:52

Tags for this article:

Click the tags to see associated articles and topics

KYE Pharmaceuticals Files Accrufer® New Drug Submission in Canada for the Treatment of .... View article details on hiswai:

Excerpt

... fulfill clinically significant unmet needs to the Canadian market, ... therapy approved by Health Canada and marketing approval for Accrufer® ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up